As a result of the significant disruption that is being caused by the COVID-19 pandemic we are very aware that many researchers will have difficulty in meeting the timelines associated with our peer review process during normal times. Please do let us know if you need additional time. Our systems will continue to remind you of the original timelines but we intend to be highly flexible at this time.
The first study to evaluate SNP variations among both patients with Dry Eye Sndrome (DES) and Sjogren’s Syndrome (SS) found the TNFα allele significantly associated with DES for homozygotes, and associated with SS for heterozygotes in the additive model.
COVID-19 and impact on peer review
View which articles have been recently trending
Sign up to receive article alerts
Journal of Inflammation is published continuously online-only and so we encourage you to sign up to receive free email alerts to keep up to date with all of the latest research by registering here.
Aims and scope
Journal of Inflammation is an open access, peer-reviewed online journal publishing articles on all aspects of research into inflammation. Non-research articles are specially commissioned by the Editors-in-Chief.
Announcing the launch of In Review
Journal of Inflammation, in partnership with Research Square, is now offering In Review. Authors choosing this free optional service will be able to:
- Share their work with fellow researchers to read, comment on, and cite even before publication
- Showcase their work to funders and others with a citable DOI while it is still under review
- Track their manuscript - including seeing when reviewers are invited, and when reports are received
Submit your review
Prof Kirkham is Professor of Cell Biology at the University of Wolverhampton and a fellow of the HEA. His research interests focus on understanding the mechanisms of disease pathogenesis driven by oxidative stress and its impact on cell function and inflammation, particularly in relation to respiratory disease.
Prof Rossi holds the position of Personal Chair in Respiratory and Inflammation Pharmacology at the University of Edinburgh. Prof Rossi is a Fellow of the Society of Biology and a Fellow of the British Pharmacological Society. His research involves investigating the cellular processes and signalling mechanisms controlling inflammation with a focus on understanding inflammation resolution.
Affiliated with the British Inflammation Research Association (BIRAs).
Annual Journal Metrics
78 days to first decision for reviewed manuscripts only
51 days to first decision for all manuscripts
117 days from submission to acceptance
14 days from acceptance to publication
2.662 - 2-year Impact Factor
2.885 - 5-year Impact Factor
0.877 - Source Normalized Impact per Paper (SNIP)
1.015 - SCImago Journal Rank (SJR)
66 Altmetric mentions